AUDAX: A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia (clinicaltrials.gov) - Sep 15, 2026 - P3 | N=560 | Not yet recruiting | Sponsor: Amgen | Trial completion date: Aug 2033 ➔ Aug 2035 | Initiation date: Jun 2026 ➔ Jun 2028 | Trial primary completion date: May 2030 ➔ Dec 2031
Trial completion date • Trial initiation date • Trial primary completion date • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology
|